Salt Lake City, Utah
Phase 1 cancer trials in Salt Lake City, UT
59 Phase 1 cancer studies are recruiting participants at sites in Salt Lake City as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Salt Lake City at a glance
- 59 studies are recruiting at a site in Salt Lake City.
- By phase: Early Phase 1 (2), Phase 1 (26), Phase 1/2 (31).
- By sponsor: industry (41), university, hospital or other (16), government (2).
- By research area: Lymphoma (26), Breast Cancer (13), Lung Cancer (12), Pancreatic Cancer (3), Prostate Cancer (3), Melanoma (2).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Salt Lake City
Basic details from each study's public record (the 30 most recently updated of 59). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT07020117 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Huntsman Cancer Institute University of Utah
- Registry record
- NCT07488676 · updated
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 19 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- Intermountain Health
- Registry record
- NCT06586957 · updated
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- University of Utah - Huntsman Cancer Institute
- Registry record
- NCT06465069 · updated
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- LigaChem Biosciences, Inc.
- Study site
- Intermountain/LDS Hospital Ph 1 Research Program
- Registry record
- NCT06774963 · updated
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Daiichi Sankyo
- Study site
- Huntsman Cancer Institute, University of Utah
- Registry record
- NCT06330064 · updated
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genentech, Inc.
- Study site
- University of Utah Huntsman Cancer Institute
- Registry record
- NCT07100106 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Salt Lake City, UT on ClinicalTrials.gov.
Lung cancer studies recruiting in Salt Lake City
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kestrel Therapeutics, Inc.
- Study site
- Huntsman Cancer Institute, University of Utah
- Registry record
- NCT07458347 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT07020221 · updated
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- University of Utah - Huntsman Cancer Institute
- Registry record
- NCT07542704 · updated
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Pierre Fabre Medicament
- Study site
- University of Utah - Huntsman Cancer Institute - PPDS
- Registry record
- NCT06043817 · updated
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- Huntsman Cancer Institute /ID# 271686
- Registry record
- NCT06772623 · updated
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Tango Therapeutics, Inc.
- Study site
- Huntsman Cancer Institute, University of Utah
- Registry record
- NCT06922591 · updated
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Tango Therapeutics, Inc.
- Study site
- University of Utah, Huntsman Cancer Institute
- Registry record
- NCT06810544 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Salt Lake City, UT on ClinicalTrials.gov.
Prostate cancer studies recruiting in Salt Lake City
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT07190300 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Salt Lake City, UT on ClinicalTrials.gov.
Melanoma studies recruiting in Salt Lake City
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Huntsman Cancer Institute/University of Utah
- Registry record
- NCT05896839 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Salt Lake City, UT on ClinicalTrials.gov.
Lymphoma studies recruiting in Salt Lake City
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- Primary Children's Hospital
- Registry record
- NCT04726241 · updated
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Debiopharm International SA
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT05765812 · updated
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study site
- Huntsman Cancer Institute, University of Utah
- Registry record
- NCT07478848 · updated
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Phase 1
- Ages 0 to 18
- All sexes
- Sponsor
- Autolus Limited
- Study site
- Primary Children's Hospital
- Registry record
- NCT06173518 · updated
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Phase 1/2
- Up to age 1
- All sexes
- Sponsor
- Tanja Andrea Gruber
- Study site
- University of Utah Huntsman Cancer Institute
- Registry record
- NCT05848687 · updated
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Huntsman Cancer Institute at The University of Utah
- Registry record
- NCT05091424 · updated
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Phase 1/2
- From 6 months, up to 25 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Intermountain - Primary Children's Hospital ( Site 1014)
- Registry record
- NCT06395103 · updated
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- Early Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AIDS Malignancy Consortium
- Study site
- Huntsman Cancer Institute/University of Utah
- Registry record
- NCT04139304 · updated
Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma
- Phase 1/2
- Ages 18 to 80
- All sexes
- Sponsor
- City of Hope Medical Center
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT05861050 · updated
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Huntsman Cancer Institute/University of Utah
- Registry record
- NCT06860594 · updated
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Curis, Inc.
- Study site
- Huntsman Cancer Institute, University of Utah
- Registry record
- NCT03328078 · updated
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Estrella Immunopharma, Inc.
- Study site
- Intermountain Health, Canyons Region, LDS Hospital
- Registry record
- NCT06343311 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Salt Lake City, UT on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Salt Lake City
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- RayzeBio, Inc.
- Registry record
- NCT07165132 · updated
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Jacobio Pharmaceuticals Co., Ltd.
- Study site
- Huntsman Cancer Institute
- Registry record
- NCT06973564 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Salt Lake City, UT on ClinicalTrials.gov.
Ask about studies near Salt Lake City
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Utah
All Utah locations
100 studies recruiting across 3 cities.
West Valley City
42 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections